SCHEMBL8625124

SCHEMBL8625124

CC(N)C(Cc1ccc(Cl)cc1)c1ccc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A2 P23975 11/20 0.47
SLC6A3 Q01959 11/20 0.47
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
SLC6A4 P31645 11/20 0.45
KCNH2 Q12809 7/20 0.45
CYP3A4 P08684 7/20 0.45
CYP2D6 P10635 7/20 0.45
CYP2A6 P11509 1/20 0.44
UGT2B7 P16662 1/20 0.42
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618784 0.91 HTR2A (0.58) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL8619607 0.89 HTR2A (0.46) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL3729575 0.88 SLC6A2 (0.54) HTR2AHTR2CHTR2BSLC6A2SLC6A3
Ammonia Solution, Strong SCHEMBL3729016 0.87 SLC6A2 (0.52) HTR2AHTR2CHTR2BSLC6A2SLC6A3
Ammonia Solution, Strong SCHEMBL3738837 0.87 SLC6A2 (0.52) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL8620876 0.86 HTR2A (0.50) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL4691720 0.83 SLC6A3 (0.62) SLC6A2SLC6A3CNR1CNR2SLC6A4
SCHEMBL5703577 0.82 HTR2A (0.47) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL8623619 0.82 HTR2A (0.47) HTR2AHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL3374924 0.82 SLC6A2 (0.56) SLC6A2SLC6A3CNR1CNR2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5777150-A Substituted amic acid derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-07-07 US disclosed
EP-0611749-B1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMA CO LTD (JP) 1997-10-22 EP disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed